Skip to content
healthcare.dev

Sitagliptin

NDC 70771-1792, Sitagliptin, tablet, from Zydus Lifesciences Limited.

Product NDC
70771-1792
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA211566
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1792 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SITAGLIPTIN100 mg/1

Pharmacologic classes

Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
70771-1792-37077117920330 TABLET in 1 BOTTLE (70771-1792-3)
70771-1792-97077117920990 TABLET in 1 BOTTLE (70771-1792-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e5ac97e8-3a0b-4750-8e3f-337412570746

Use it

Look up 70771-1792 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1792 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1792. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.